Kennametal Inc <KMT.N>: JP Morgan cuts target price to $34 from $40
KMT•Related News
Moleculin Biotech reports interim MIRACLE trial data showing higher remission rates in relapsed/refractory AML
MBRX•
Crinetics-Vertex deal clears US antitrust waiting period, other approvals in hand
CRNX•
U.S. equity funds draw inflows as rate-hike concerns ease
SPY•
Proficient Auto Logistics completes acquisition of Hansen & Adkins
PAL•
Leatt Q2 FY26 net income drops 20% to USD 908,989; revenue rises 1% to USD 16.39 million
LEAT•